Once Weekly Selinexor, Bortezomib, and Dexamethasone Versus Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Age and Frailty Subgroup Analyses from the Phase 3 Boston Study - Auner,HW; Gavriatopoulou,M; Delimpasi,S; Simonova,M; Spicka,I; Pour,L; Dimopoulos,MA; Kryachok,I; Pylypenko,H; Leleu,X; Doronin,VA; Usenko,G; et al. (AMER SOC HEMATOLOGY, 2020)